Overview

cPass Neutralization Antibody Detection kit detects circulating neutralizing antibodies against SARS-CoV-2 that block the interaction between the receptor binding domain (RBD) of the viral spike glycoprotein with the ACE2 cell surface receptor. The cPass test is now authorized for semi-quantitative detection that provides a relative concentration result of an adaptive immune response to recent SARS-CoV-2 infection.

Placing An Order

covid 19 diagnostics svnt

cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit

Authorization
FDA EUA
Size
96 Test
Quantity
Get A Quote

A02087 SARS-CoV-2 Neutralizing Antibody Calibrator is now FDA authorized under Emergency Use Authorization with cPass SARS-CoV-2 Neutralization Antibody Detection Kit for semi-quantitative results. New

Notice! Customers should be aware that they may receive product with original packaging prior to the updated FDA EUA authorization November 12, 2021. Such packaging retains the original 6 month expiration, manufacturer address, and IFU for qualitative use. The current inventory is qualified for the expiration extension to 9 months. Should you have questions about your order's expiration, do not hesitate to contact us to provide updated information related to your order. All kit lots manufactured after February 1, 2022 will include the new authorized labeling.

See below additional details related to a list of kit lots with original packaging. An outline of label changes can be found in the Resources section.

Kit lots with packaging prior to November 12, 2021*:

pTitle border="0" cellspacing="0" cellpadding="0" class="basicTable" width="100%"> Lot # Original Expiration Extended ExpirationNew A210506 November 16, 2022 February 16, 2022 A210603 December 2, 2022 March 2, 2022 A210604 December 6, 2022 March 6, 2022

Note:
*Expiration extension applies to current GenScript inventory. If your order includes one of these kit lots, you will be informed that they include the original labels and they are eligible for the updated expiration per the updated FDA authorization dated November 12, 2021. The new expiration will be included on your quote and order.

Product Details

Features

Isotype Independent

High Specificity

High Sensitivity

Safe & Scalable

Technology

feedback

Do you like the current new website?

Hate

Dislike

Neutral

Like

Love

*